Delivery Order SPE2DB24D8002-SPE2DB24FJMXG
Award Date
9/10/24
Potential Completion Date
9/11/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,783.81 firm fixed-price contract is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has a period of performance through February 24, 2025. Dakota Drug, Inc. is a key supplier to the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop Support Medical's ECAT...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,946.91 firm fixed-price contract is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of November 7, 2023. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $2,073.16 firm fixed-price contract is for the delivery of 100 units of the prescription medication Vyvanse 40 mg capsules. This award falls under Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
This federal contract award, valued at $1,461.18, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 100 units of the medication VYVANSE 30 MG CAPSULE. The contract has a firm fixed price pricing type and an ultimate completion date of August 15, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This contract...
The Defense Logistics Agency (DLA) awarded a $1,461.18 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4,565,228,290 units of the prescription medication Vyvanse 50 mg capsules. This order falls under Dakota Drug's Indefinite Delivery Contract (IDC) SPE2DB24D8001 with DLA Troop Support Medical, a $999,999,999.00 single-award contract that enables the company to supply a range of pharmaceutical products, medical supplies,...
This is a $2,157.72 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, with a period of performance ending on November 25, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT Generation V Program. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $3,155.20 and a period of performance through October 31, 2024. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of the DLA Troop...
This is a $1,979.66 firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is for the delivery of 4562235206 VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC is part of the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of VYVANSE 70 MG CAPSULE 100S. The firm-fixed-price contract has a ceiling value of $1,054.23 and a period of performance through November 22, 2023. Dakota Drug, Inc. is an established vendor for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) to provide a wide range of pharmaceuticals,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,461.76 firm-fixed-price contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a prescription medication, with a completion date of February 7, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, valued at $999,999,999.00. This IDC, part of the DLA Troop Support Medical's ECAT...